Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.
about
Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequencesEstrogen as therapy for breast cancer.Current Medical Treatment of Patients with Non-Colorectal Liver Metastases: Primary Tumor Breast CancerThe effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alphaAlterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancerTamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancerPrediction of cancer drugs by chemical-chemical interactionsCoprescription of tamoxifen and medications that inhibit CYP2D6.Chains of evidence, mosaics of data: does estrogen 'cause' breast cancer? How would we know?The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancer.Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents.Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis.Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients.The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.Second-line treatment of postmenopausal women with advanced breast carcinoma.Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors.Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?Oestrogen receptors in breast cancer: basic mechanisms and clinical implications.Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure.Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix.Additive endocrine therapy for advanced breast cancer - back to the future.Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network StudyCharacterization of endocrine disruptors from a complex matrix using estrogen receptor affinity columns and high performance liquid chromatography-high resolution mass spectrometry.Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy.The oestrogen paradox: an hypothesis.Human UDP-Glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are Inhibited by Diethylstilbestrol.A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.Molecular mechanisms of hormone resistance of breast cancer.
P2860
Q24682430-D4070545-F309-4B05-9917-F377C7EB7B61Q24802521-B4C04193-16ED-4849-8D7D-D9408F11BB04Q26764987-FD7CDD16-7DBA-40EC-B6A1-3CF8A0CA9596Q28237115-5D2E000D-EBF2-4E18-AB17-0DCFE3B6A3A7Q28344327-58BBBA03-CBC5-4DC4-ADE3-4C6E1653330EQ28481232-8B18A972-6946-43A2-BB88-A0429692C535Q28539449-DB0DD7F4-C4B2-4314-93CC-99718D230D5BQ33898184-18CF8685-F8F9-4B28-B87E-9FC09E6101BDQ34285969-CD29BC99-BC76-457C-82CA-D6A251D0CF1FQ34311300-0EADB1B0-5708-4A18-AA5E-1A1EC0DF1209Q34362281-D940C76B-3DDD-47F9-8FBA-BF3D912FABFEQ34458253-C51A177D-86BC-4497-9AC3-F6856EF27C0BQ34944679-E710F802-FB45-4FCE-8CDE-6EF9EDBC97EBQ35002418-5B19BB1E-20E5-4F07-82A8-18A33AB028D8Q35750078-D96F05CA-D241-4B95-8645-7F26A00A4B1FQ35821415-40773A7D-694D-49CD-AF88-14A0C75107E5Q35827822-8BE5D755-FBBF-4A0C-AAF7-2FA6102CA357Q36011096-F9258805-0B5F-4458-84FC-C72F27A934B9Q36448699-CF86574D-3252-4D3D-991E-0BB66A8D996DQ36693861-F47C009A-8FA0-4057-B081-673FA994D13DQ37277121-80269C38-F644-43BE-80E7-5FD85787941EQ37277897-5AEF3E6E-F740-4C21-8B7E-FE5358D153C8Q37340411-46A65D48-63FE-41F5-86B9-E295E17A6167Q37346786-FD2E2E89-D9A7-412D-B515-32A795864725Q37622884-F2DA1E52-34C0-4A75-AAD8-0CB4686EDE84Q38352305-E94C7B21-078A-415F-AD43-07103A1056B5Q40773847-0A463BA7-EEFA-4F2E-8636-069BD0F88438Q42713403-3A763F6A-F3D9-4276-B869-7E30222B8DD2Q43614271-00199D12-A087-45EF-A757-15F76631E7DEQ43717824-5211F656-F880-4BE9-B3ED-4A995F67E01EQ45788428-ECF0E948-A521-44B0-A068-644B42F1EC84Q46548809-F1101D43-207C-4F87-8DD8-0F546CBDDFC0Q47825566-9A59961F-86BF-4CDE-B638-3DDA8A7A65D5Q53086084-A0166286-494D-4CF3-A2BE-EFEB98DE984B
P2860
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Randomized trial of diethylsti ...... t cancer. An updated analysis.
@ast
Randomized trial of diethylsti ...... t cancer. An updated analysis.
@en
type
label
Randomized trial of diethylsti ...... t cancer. An updated analysis.
@ast
Randomized trial of diethylsti ...... t cancer. An updated analysis.
@en
prefLabel
Randomized trial of diethylsti ...... t cancer. An updated analysis.
@ast
Randomized trial of diethylsti ...... t cancer. An updated analysis.
@en
P2093
P2860
P356
P1476
Randomized trial of diethylsti ...... t cancer. An updated analysis.
@en
P2093
Hartmann LC
Loprinzi CL
Peethambaram PP
P2860
P2888
P304
P356
10.1023/A:1006185805079
P407
P577
1999-03-01T00:00:00Z
P6179
1000717306